Loading
Latest filing published 13 Aug 2024 for Pediatrix Medical Group, Inc., €301k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
C. Marc Richards, listed as chief executive, appears in our data through filings on Pediatrix Medical Group, Inc. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 1 March 2022 to 9 August 2024.
On the market, this insider has only sold: 1 sale, €301k in total. The rest of the record consists of 4 share grants. 2024 to date brings no purchases and 1 sale.
The latest filing, published on 13 August 2024, reports an open-market sale of €301k in Pediatrix Medical Group, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations